Illumina, Inc. ILMN
$166.12
▼ -3.15% 24H
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and r…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees8,600
TickerILMN
Statistics
Market Cap$25.25B
Revenue (TTM)$4.34B
Net Income$850.0M
Net Margin19.6%
EPS$5.45
P/E30.17
P/S5.72
P/B9.44
EV/EBITDA22.48
ROE33.8%
Dividend Yield—
Price$166.12
Data: Twelve Data · Revenue = mcap / P/S